Abstracts of the 88th Annual Meeting of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT).
- Published in:
- 2022
- Publication type:
- Abstract
Works matching IS 00281298 AND DT 2022 AND VI 395 AND IP 1
Results: 14
1
2
Metalloproteinases and their inhibitors in neurological disease.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2022, v. 395, n. 1, p. 27, doi. 10.1007/s00210-021-02188-x
- By:
- Publication type:
- Article
3
Lack of miRNA-17 family mediates high glucose-induced PAR-1 upregulation in glomerular mesangial cells.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2022, v. 395, n. 1, p. 77, doi. 10.1007/s00210-021-02184-1
- By:
- Publication type:
- Article
4
Correction to: Hydroxyurea-loaded Fe<sub>3</sub>O<sub>4</sub>/SiO<sub>2</sub>/chitosan-g-mPEG2000 nanoparticles; pH-dependent drug release and evaluation of cell cycle arrest and altering p53 and lincRNA-p21 genes expression.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
5
Correction to: Pharmacological stimulation of sigma-1 receptor promotes activation of astrocyte via ERK1/2 and GSK3β signaling pathway.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
6
Research progress on the occurrence and therapeutic mechanism of ferroptosis in NSCLC.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2022, v. 395, n. 1, p. 1, doi. 10.1007/s00210-021-02178-z
- By:
- Publication type:
- Article
7
Protective effects of melatonin and l-carnitine against methotrexate-induced toxicity in isolated rat hepatocytes.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2022, v. 395, n. 1, p. 87, doi. 10.1007/s00210-021-02176-1
- By:
- Publication type:
- Article
8
Metabolite transporters as regulators of macrophage polarization.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2022, v. 395, n. 1, p. 13, doi. 10.1007/s00210-021-02173-4
- By:
- Publication type:
- Article
9
Aconitine linoleate, a natural lipo-diterpenoid alkaloid, stimulates anti-proliferative activity reversing doxorubicin resistance in MCF-7/ADR breast cancer cells as a selective topoisomerase IIα inhibitor.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2022, v. 395, n. 1, p. 65, doi. 10.1007/s00210-021-02172-5
- By:
- Publication type:
- Article
10
Lithium modulates multiple tau kinases with distinct effects in cortical and hippocampal neurons according to concentration ranges.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2022, v. 395, n. 1, p. 105, doi. 10.1007/s00210-021-02171-6
- By:
- Publication type:
- Article
11
Association and pharmacological synergism of the triple drug therapy baricitinib/remdesivir/rhACE2 for the management of COVID-19 infection.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2022, v. 395, n. 1, p. 99, doi. 10.1007/s00210-021-02169-0
- By:
- Publication type:
- Article
12
Hydroxyurea-loaded Fe<sub>3</sub>O<sub>4</sub>/SiO<sub>2</sub>/chitosan-g-mPEG2000 nanoparticles; pH-dependent drug release and evaluation of cell cycle arrest and altering p53 and lincRNA-p21 genes expression.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2022, v. 395, n. 1, p. 51, doi. 10.1007/s00210-021-02168-1
- By:
- Publication type:
- Article
13
Gender-specific analysis of the authors and the editorial board of Naunyn–Schmiedeberg's Archives of Pharmacology from 2000 to 2020.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2022, v. 395, n. 1, p. 39, doi. 10.1007/s00210-021-02166-3
- By:
- Publication type:
- Article
14
Correction to: The renin‑angiotensin system and specifically angiotensin‑converting enzyme 2 as a potential therapeutic target in SARS‑CoV‑2 infections.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice